Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cosmo Pharmaceuticals NV
Accounts Receivables Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Accounts Receivables
€23.6m
CAGR 3-Years
13%
CAGR 5-Years
18%
CAGR 10-Years
3%
Perrigo Company PLC
NYSE:PRGO
Accounts Receivables
$813.3m
CAGR 3-Years
4%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Accounts Receivables
$723.6m
CAGR 3-Years
13%
CAGR 5-Years
22%
CAGR 10-Years
14%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Accounts Receivables
$33.4m
CAGR 3-Years
396%
CAGR 5-Years
25%
CAGR 10-Years
25%
G
GH Research PLC
NASDAQ:GHRS
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Accounts Receivables
€175k
CAGR 3-Years
25%
CAGR 5-Years
2%
CAGR 10-Years
-7%

See Also

What is Cosmo Pharmaceuticals NV's Accounts Receivables?
Accounts Receivables
23.6m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Accounts Receivables amounts to 23.6m EUR.

What is Cosmo Pharmaceuticals NV's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
3%

Over the last year, the Accounts Receivables growth was -30%. The average annual Accounts Receivables growth rates for Cosmo Pharmaceuticals NV have been 13% over the past three years , 18% over the past five years , and 3% over the past ten years .

Back to Top